0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 6
  • 6
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1

PRICE

0
0
1
26

PUBLISHED

0
5
21
26

PRODUCT TYPE

25
1

Search for: "Jenrin Discovery, Inc.-Therapeutic Competitors Report"

Jenrin Discovery, Inc. - Product Pipeline Review - 2016

Jenrin Discovery, Inc. - Product Pipeline Review - 2016 Summary ‘Jenrin Discovery, Inc. - Product Pipeline Review - 2016’, provides an overview of the Jenrin Discovery, Inc.’s pharmaceutical research...

Published:  March 2016
Price:  From

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015

Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015 Summary The report ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s...

Published:  October 2015
Price:  From

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2016

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2016 Summary The report ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2016’, provides an overview of the Non-Alcoholic Steatohepatitis pipeline...

Published:  February 2016
Price:  From

Dyslipidemia - Pipeline Review, H1 2016

Dyslipidemia - Pipeline Review, H1 2016 Summary ‘Dyslipidemia - Pipeline Review, H1 2016’, provides an overview of the Dyslipidemia pipeline landscape. The report provides comprehensive information...

Published:  March 2016
Price:  From

Obesity - Pipeline Review, H1 2015

Obesity - Pipeline Review, H1 2015 Summary This, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

Published:  February 2015
Price:  From

Obesity - Pipeline Review, H2 2015

Obesity - Pipeline Review, H2 2015 Summary The report ‘Obesity - Pipeline Review, H2 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information...

Published:  December 2015
Price:  From

Osteoarthritis - Pipeline Review, H2 2015

Osteoarthritis - Pipeline Review, H2 2015 Summary The report ‘Osteoarthritis - Pipeline Review, H2 2015’, provides an overview of the Osteoarthritis’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

Atherosclerosis - Pipeline Review, H2 2015

Atherosclerosis - Pipeline Review, H2 2015 Summary The report ‘Atherosclerosis - Pipeline Review, H2 2015’, provides an overview of the Atherosclerosis’s therapeutic pipeline. This report provides...

Published:  December 2015
Price:  From

Diabetic Nephropathy - Pipeline Review, H1 2016

Diabetic Nephropathy - Pipeline Review, H1 2016 Summary The report ‘Diabetic Nephropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Nephropathy pipeline landscape. The report...

Published:  February 2016
Price:  From

Diabetic Nephropathy - Pipeline Review, H2 2015

Diabetic Nephropathy - Pipeline Review, H2 2015 Summary The report ‘Diabetic Nephropathy - Pipeline Review, H2 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline. This...

Published:  November 2015
Price:  From

Atherosclerosis - Pipeline Review, H1 2015

Atherosclerosis - Pipeline Review, H1 2015 Summary This, ‘Atherosclerosis - Pipeline Review, H1 2015’, provides an overview of the Atherosclerosis’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Osteoarthritis - Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Osteoarthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism...

Published:  June 2015
Price:  From

Diabetic Nephropathy - Pipeline Review, H1 2015

Diabetic Nephropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Nephropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline. This report...

Published:  January 2015
Price:  From

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015 Summary This, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic...

Published:  January 2015
Price:  From

Type 2 Diabetes - Pipeline Review, H2 2015

Type 2 Diabetes - Pipeline Review, H2 2015 Summary The report ‘Type 2 Diabetes - Pipeline Review, H2 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides...

Published:  December 2015
Price:  From

Dyslipidemia - Pipeline Review, H1 2015

Dyslipidemia - Pipeline Review, H1 2015 Summary This, ‘Dyslipidemia - Pipeline Review, H1 2015’, provides an overview of the Dyslipidemia’s therapeutic pipeline. This report provides comprehensive...

Published:  January 2015
Price:  From

Osteoarthritis - Pipeline Review, H1 2016

Osteoarthritis - Pipeline Review, H1 2016 Summary ‘Osteoarthritis - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis pipeline landscape. The report provides comprehensive information...

Published:  March 2016
Price:  From

Inflammatory Bowel Disease - Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

Published:  June 2015
Price:  From

Liver Cancer - Pipeline Review, H2 2015

Liver Cancer - Pipeline Review, H2 2015 Summary The report ‘Liver Cancer - Pipeline Review, H2 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

Dyslipidemia - Pipeline Review, H2 2015

Dyslipidemia - Pipeline Review, H2 2015 Summary The report ‘Dyslipidemia - Pipeline Review, H2 2015’, provides an overview of the Dyslipidemia’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation